We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Behavioral Neuroscience – Webinars and Online Events

Ask me anything on the chemistry of psilocybin featuring andrew wood
Ask Me Anything

Ask Me Anything: The Chemistry of Psilocybin

On-Demand
Explore the chemistry of psilocybin with esteemed chemist Andrew Wood in our recent AMA. Delve into the scientific aspects, including analytical methods and mechanisms of action. Gain a deeper understanding of psychedelics and their impact.
Ask Me Anything

Ask Me Anything: Psychedelics

On-Demand
An incredible opportunity to ask Professor Boris Heifets anything about the world of Psychedelics.
Webinar

The Neuroscience of Psychedelics – Harnessing Neuroplasticity for New Therapeutics

On-Demand
Join Dr. Reichelt on December 14 for this exclusive webinar which will explore the neurobiology of psychedelics, emphasizing their role in promoting neuroplasticity.
Psychedelics in Psychiatry content piece image
Webinar

Psychedelics in Psychiatry

On-Demand
Join Prof. Matthew Johnson, PhD, Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine as he explores how psychedelics may be leveraged in the treatment of a variety of nominally distinct psychiatric disorders.
Improving Cognitive and Gait Control in Parkinson’s with Vagus Nerve Stimulation content piece image
Webinar

Improving Cognitive and Gait Control in Parkinson’s with Vagus Nerve Stimulation

On-Demand

In this webinar, we will summarise the current literature on non-invasive VNS in Parkinson’s disease and discuss preliminary findings of its therapeutic potential with an emphasis on its efficacy in improving cognitive and gait control in people with Parkinson’s.
The Potential of Psychedelic Medicine to Transform Mental Health Treatment content piece image
Webinar

The Potential of Psychedelic Medicine to Transform Mental Health Treatment

On-Demand
In this presentation, Cosmo Feilding-Mellen, co-founder and chief executive of Oxford-based psychedelic medicine company Beckley Psytech will take stock of the current psychedelic innovation landscape and the vast potential for psychedelic treatments in healthcare.
Advertisement